Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations
06:46am, Friday, 05'th Nov 2021
Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Consolidated Product revenues were $978 million, while Service and other revenues
Illumina, Inc. (ILMN) CEO Francis Desouza Q3 2021 Results - Earnings Call Transcript
10:08pm, Thursday, 04'th Nov 2021
Illumina, Inc. (ILMN) CEO Francis Desouza Q3 2021 Results - Earnings Call Transcript
Illumina (ILMN) Surpasses Q3 Earnings and Revenue Estimates
07:04pm, Thursday, 04'th Nov 2021
Illumina (ILMN) delivered earnings and revenue surprises of 16.94% and 6.63%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
EXEL vs. ILMN: Which Stock Is the Better Value Option?
01:00pm, Wednesday, 03'rd Nov 2021
EXEL vs. ILMN: Which Stock Is the Better Value Option?
EC Adopts Interim Measure, Tells Grail To Work On Alternatives To Illumina Deal
12:04pm, Friday, 29'th Oct 2021
The European Commission (EC) told Grail to "actively work" on alternatives to its acquisition by Illumina Inc (NASDAQ: ILMN) if the takeover is ultimately blocked in the internal market. Related
EU orders Illumina to keep Grail a separate company
06:29am, Friday, 29'th Oct 2021
The European Commission said on Friday it had taken interim measures following life science company Illumina's early acquisition of cancer detection test maker Grail Inc, including an order that Grail
Final Trades: Illumina, JPMorgan, AMD, Qualcomm & more
01:43pm, Monday, 25'th Oct 2021
The "Halftime Report" traders give their top picks to watch for the second half.
Let Go of These 4 Toxic Stocks Right Away
10:58am, Thursday, 21'st Oct 2021
Steer clear of toxic stocks like SRI, ILMN, TPIC and JD to safeguard your portfolio from losses.
Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL
07:35pm, Thursday, 14'th Oct 2021
SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that Bob Ragusa has been appointed as Chief Executive Officer of GRAIL, a healthcare company whose mission is foc
Illumina to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021
05:00pm, Wednesday, 13'th Oct 2021
SAN DIEGO, Oct. 13, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2021 following the close of market on Thursday, November 4, 2021
EU antitrust regulators resume Illumina, Grail probe, decision due by Feb. 4
05:31am, Tuesday, 12'th Oct 2021
EU antitrust regulators have resumed their scrutiny of U.S. life sciences company Illumina's bid for Grail Inc after a two-month temporary halt and will decide by Feb. 4 whether to clear the deal, a E
Why Shares of Ilumina Slumped 11.3% in September
06:26pm, Wednesday, 06'th Oct 2021
The company's merger with GRAIL concerned investors.
Illumina (ILMN) Oncology Growth Aids Amid GRAIL Merger Hurdle
11:42am, Friday, 01'st Oct 2021
Illumina (ILMN) is making progress outside the United States to ensure all expecting families have access to NIPT.
Illumina Expands Presence in Latin America
09:15am, Thursday, 30'th Sep 2021
SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced the creation of Illumina Colombia S.A.S.
Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infants
11:08am, Monday, 27'th Sep 2021
SAN DIEGO, Sept. 27, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) scientists, together with investigators from five children's hospital across the US, have co-authored a study published today i
